American Society of Hematology Announces 2023 Scholar Award Recipients
(WASHINGTON, Feb. 2, 2023) — The American Society of Hematology (ASH) today announced the 33 recipients of its 2023 Scholar Awards. One of ASH’s most prestigious research award programs, the ASH Scholar Awards support early career investigators dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.
Each Scholar Award provides $100,000 for the Fellow level, $125,000 for the Fellow to Faculty Scholars level, or $150,000 for the Junior Faculty level. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders.
“The ASH Scholar Award provides vital recognition for emerging research scientists. The prize not only acknowledges their contributions to the field of hematology, but also provides them with the resources and support they need to continue their pioneering work,” said 2023 ASH President, Robert A. Brodsky, MD, of Johns Hopkins University School of Medicine. “For more than 35 years now, ASH has supported fellows and early career faculty who go on to make a lasting impact on hematology. We congratulate this year’s recipients and look forward to watching them transform the field and improve the care of individuals living with blood disorders.”
The 2023 Scholar Awards recipients are:
Basic/Translational Fellow
Jacob Appelbaum, MD, PhD, Fred Hutchinson Cancer Center
Senthil Velan Bhoopalan, MBBS, PhD, St. Jude Children's Research Hospital
Giulia Biancon, PhD, Yale University School of Medicine
Emily Heikamp, MD, PhD, Dana-Farber Cancer Institute
Michael Kramer, MD, PhD, Washington University School of Medicine
Richa Sharma, MD, St Jude Children's Research Hospital
Clinical Fellow
Regina Myers, MD, Children's Hospital of Philadelphia
Basic/Translational Fellow to Faculty
Xufeng Chen, PhD, NYU Grossman School of Medicine
Orsola Di Martino, PhD, Washington University School of Medicine
Jana Ellegast, MD, Dana-Farber Cancer Institute
Xin Gao, PhD, University of Wisconsin School of Medicine and Public Health
Casey Katerndahl, PhD, Washington University School of Medicine
Stephen Persaud, MD, PhD, Washington University School of Medicine
Abhishek Singh, PhD, University of Cincinnati College of Medicine
Basic/Translational Junior Faculty
Timothy Chlon, PhD, Cincinnati Children’s Hospital Medical Center
Kyle Cromer, PhD, MPhil, University of California, San Francisco
Agnieszka Czechowicz, MD, PhD, Stanford University
Cihangir Duy, PhD, Fox Chase Cancer Center
Oleg Kim, PhD, University of Pennsylvania
M. Eric Kohler, MD, PhD, University of Colorado Anschutz Medical Campus
Rebecca Luchtel, PhD, Northwestern University
Sydney Lu, MD, PhD, Stanford University
Maria Maryanovich, PhD, Albert Einstein College of Medicine
Zhangli Peng, PhD, University of Illinois at Chicago
Koushik Roy, PhD, University of Utah
Zohar Sachs, MD, PhD, University of Minnesota Medical School
Alan Shih, MD, PhD, Icahn School of Medicine at Mount Sinai
Clinical Junior Faculty
Matthew Frank, MD, PhD, Stanford University
Casey McAtee, MD, MPH, Baylor College of Medicine
Afaf Osman, MD, University of Utah, Huntsman Cancer Institute
Charity Oyedeji, MD, Duke University
Daniel Richardson, MD, MSc, MA, University of North Carolina
Urvi A. Shah, MD, Memorial Sloan Kettering Cancer Center
ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH gratefully acknowledges this year’s supporters: AstraZeneca, Bristol Myers Squibb, the Deerfield Foundation, and Pharmacyclics LLC.
ASH commits approximately $13 million annually in support of the careers of the next generation of leaders in the field of hematology through the Society’s awards and career development programs.
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH’s flagship journal, Blood, is the most cited peer-reviewed publication in the field, and Blood Advances is an open-access, online journal that publishes more peer-reviewed hematology research than any other academic journal worldwide.
Contact:
Kira Sampson, American Society of Hematology
ksampson@hematology.org; 202-499-1796